collaborate on diagrams: https://drive.google.com/file/d/1uELuB8yGMp1Xvmu_HttxmUK-au7xq-YM/view?usp=sharing
main considerations
how will the "lobby" DNA structure change?
how will membrane access change?
how will the desktop app change?
do we want to make the desktop app interoperable with the We applet? How will this affect the current registration flow and architecture?
architecture considerations